Subscription is FREE for qualified healthcare professionals in the US.

All Opioids Articles

Topical analgesics for treating musculoskeletal pain, osteoarthritis, post-herpetic neuralgia, and peripheral neuropathy.
Chronic pain remains the same or gets better after stopping opioid treatment, according to a new study.
Medications which are commonly prescribed to people with dementia have been linked to an increase in harmful side-effects.
Agency continues its efforts to broaden access to generic versions of opioids formulated to deter abuse.
FDA will complete its review of REMOXY ER in August 2018.
This article provides a sneak preview into the upcoming July/August 2018 issue of Practical Pain Management.
The agency said it will continue to evaluate the use of market drugs and take regulatory action where needed.
With opioid misuse and abuse on the rise, other opioid receptors may be targeted for pain relief.
Knowing a patient has consumed their prescribed medication may prevent improper diversion of pills and overdose.
If approved by FDA, IV tramadol would be the first Schedule IV intravenous opioid in the US.
AcelRx is planning on resubmitting an NDA for DSUVIA to FDA in Q2 2018.
Elevated use of gabapentinoid misuse and abuse may be a problem with monitoring opioids.
With appropriate treatment and follow-up, individuals can reach sustained long-term remission from OUD.
UN calls untreated pain cruel and inhumane, yet in the US chronic pain patients are losing access to needed opioid therapy to manage severe, intractable pain conditions.
Readers raise questions about the one-sided view of the so-called opioid-epidemic, hormone therapy, and long-term opioid care.